Literature DB >> 34049359

Letter to Editor: COVID-19 in Kidney Transplant Recipients Vaccinated with Oxford-AstraZeneca COVID-19 vaccine (Covishield): A Single Center Experience from India.

Hari Shankar Meshram1, Vivek B Kute, Nauka Shah, Sanshriti Chauhan, Vijay V Navadiya, Ansy H Patel, Himanshu V Patel, Divyesh Engineer, Subho Banerjee, Jamal Rizvi, Vineet V Mishra.   

Abstract

Entities:  

Year:  2021        PMID： 34049359     DOI： 10.1097/TP.0000000000003835

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  8 in total

1.  Consequences of the first and second COVID-19 wave on kidney transplant recipients at a large Indian transplant centre.

Authors:  Vivek B Kute; Hari Shankar Meshram; Vijay V Navadiya; Sanshriti Chauhan; Dev D Patel; Sudeep N Desai; Nauka Shah; Ruchir B Dave; Subho Banerjee; Divyesh P Engineer; Himanshu V Patel; Syed Jamal Rizvi; Vineet V Mishra
Journal:  Nephrology (Carlton)       Date:  2021-08-21       Impact factor: 2.358

2.  SARS-CoV-2-specific humoral and cell-mediated immune responses after immunization with inactivated COVID-19 vaccine in kidney transplant recipients (CVIM 1 study).

Authors:  Jackrapong Bruminhent; Chavachol Setthaudom; Pongsathon Chaumdee; Sarinya Boongird; Sasisopin Kiertiburanakul; Kumthorn Malathum; Arkom Nongnuch; Angsana Phuphuakrat; Sopon Jirasiritham; Chitimaporn Janphram; Sansanee Thotsiri; Supparat Upama; Montira Assanatham
Journal:  Am J Transplant       Date:  2021-12-06       Impact factor: 9.369

3.  Mucormycosis as SARS-CoV2 sequelae in kidney transplant recipients: a single-center experience from India.

Authors:  Hari Shankar Meshram; Vivek B Kute; Sanshriti Chauhan; Ruchir Dave; Himanshu Patel; Subho Banerjee; Sudeep Desai; Deepak Kumar; Vijay Navadiya; Vineet Mishra
Journal:  Int Urol Nephrol       Date:  2021-11-18       Impact factor: 2.370

4.  Benefits of Inactivated Vaccine and Viral Vector Vaccine Immunization on COVID-19 Infection in Kidney Transplant Recipients.

Authors:  Napun Sutharattanapong; Sansanee Thotsiri; Surasak Kantachuvesiri; Punlop Wiwattanathum
Journal:  Vaccines (Basel)       Date:  2022-04-08

5.  Seroconversion Rate After SARS-CoV-2 Infection and Two Doses of Either ChAdOx1-nCOV COVISHIELD™ or BBV-152 COVAXIN™ Vaccination in Renal Allograft Recipients: An Experience of Two Public and Private Tertiary Care Center.

Authors:  Narayan Prasad; Shyam Bihari Bansal; Brijesh Yadav; Neha Manhas; Deependra Yadav; Sonam Gautam; Ravishankar Kushwaha; Ankita Singh; Dharmendra Bhadauria; Monika Yachha; Manas Ranjan Behera; Anupama Kaul
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

6.  Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD.

Authors:  Edward J Carr; Andreas Kronbichler; Matthew Graham-Brown; Graham Abra; Christos Argyropoulos; Lorraine Harper; Edgar V Lerma; Rita S Suri; Joel Topf; Michelle Willicombe; Swapnil Hiremath
Journal:  Kidney Int Rep       Date:  2021-07-06

7.  Anti-SARS-CoV-2 Antibody Level among Renal Transplant Recipients: A Case Report from Nepal.

Authors:  Kamal Ranabhat; Bhuvan Saud; Saroj Adhikari; Suraj Bhattarai; Rojan Adhikari; Bhoj Raj Luitel; Mahesh Raj Sigdel
Journal:  Case Rep Urol       Date:  2022-01-10

8.  A case report of successful kidney transplantation from a deceased donor with terminal COVID-19-related lung damage: Ongoing dilemma between discarding and accepting organs in COVID-19 era!

Authors:  Hari Shankar Meshram; Vivek B Kute; Himanshu Patel; Sudeep Desai; Sanshriti Chauhan; Ruchir B Dave
Journal:  Transpl Infect Dis       Date:  2021-07-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.